These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37201904)

  • 1. The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership.
    Harman KE; Barha J; Chalmers JR; Dart JKG; Davies I; Ellis P; Grindlay D; Hampton PJ; Hill S; Hockey S; Lloyd-Lavery A; McPhee M; Murphy R; Rauz S; Setterfield JF; Thompson I; Westmoreland M; Waistell C
    Br J Dermatol; 2023 Sep; 189(4):469-498. PubMed ID: 37201904
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
    Russo R; Cozzani E; Gasparini G; Parodi A
    Dermatol Ther; 2020 Jan; 33(1):e13190. PubMed ID: 31863534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of mucous membranes in autoimmune bullous diseases].
    Günther C
    Hautarzt; 2016 Oct; 67(10):774-779. PubMed ID: 27631412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral manifestations of benign mucous membrane pemphigus (mucous membrane pemphigoid); review of the literature and report of fifteen cases.
    SHKLAR G; McCARTHY PL
    Oral Surg Oral Med Oral Pathol; 1959 Aug; 12(8):950-66. PubMed ID: 13674694
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.
    Rashid H; Meijer JM; Bolling MC; Horváth B
    Br J Dermatol; 2022 Apr; 186(4):721-723. PubMed ID: 34747507
    [No Abstract]   [Full Text] [Related]  

  • 7. A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.
    Lee J; Seiffert-Sinha K; Attwood K; Sinha AA
    Front Immunol; 2019; 10():2219. PubMed ID: 31608053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
    Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
    Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in autoimmune pemphigoid diseases: Indications, optimized regimens, and practice gaps.
    Thomas RM; Colon A; Motaparthi K
    Clin Dermatol; 2020; 38(3):384-396. PubMed ID: 32563354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pemphigus foliaceus in a mucous membrane pemphigoid patient: An insight into possible mechanism eliciting a distinct autoimmune bullous disease in a rare anti-basement membrane autoimmunity.
    Shimoda-Komatsu Y; Fukui K; Yamazaki Y; Ohyama M
    J Dermatol; 2021 May; 48(5):710-714. PubMed ID: 33725421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica.
    Broussard KC; Leung TG; Moradi A; Thorne JE; Fine JD
    Clin Dermatol; 2016; 34(2):205-13. PubMed ID: 26903186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoimmune bullous diseases.
    Wakelin SH; Black MM
    J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
    [No Abstract]   [Full Text] [Related]  

  • 15. The top 10 research priorities for skin cancer surgery in the UK: results of a James Lind Alliance Priority Setting Partnership.
    Brown AC; Earp EM; Veitch D; Wernham A;
    Br J Dermatol; 2023 Jan; 188(1):141-142. PubMed ID: 36689506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
    Langan SM; Smeeth L; Hubbard R; Fleming KM; Smith CJ; West J
    BMJ; 2008 Jul; 337(7662):a180. PubMed ID: 18614511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal cicatricial mucous membrane pemphigoid of the trachea.
    DERBES VJ; PITOT HC; CHERNOSKY ME
    Dermatol Trop Ecol Geogr; 1962 Jul; 1():114-7. PubMed ID: 13885553
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research priorities for shoulder surgery: results of the 2015 James Lind Alliance patient and clinician priority setting partnership.
    Rangan A; Upadhaya S; Regan S; Toye F; Rees JL
    BMJ Open; 2016 Apr; 6(4):e010412. PubMed ID: 27067892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.